Search

2621 Results

Last update: : 03.02.2025

Ann-Katrin Schlosser +49 6221 42 3822 D410 Research Project Therapeutic vaccination against orthotopic HPV-dependent cancers in MHC-humanized mice Many therapeutic vaccines against HPV-driven…

Last update: : 03.02.2025

Prof. Dr. Hedda Wardemann +49 6221 42 1270 +49 6221 42 1279 D130 Division Head

JC-CanImm_Titles.pdf PDF, 72.73 KB

Last update: : 03.02.2025

Journal Club Cancer Immunotherapy 2015 Chauvin et al., 2015 JCI Mascanfroni et al., Nature Med 2015 Spranger et al., 2015 Nature Kreiter et al., 2015 Nature Surace et al. 2015 Twyman-Saint Victor et…

Document

Last update: : 03.02.2025

Press releases Stay informed about the latest developments and research results of the German Cancer Research Center. To the press releases Download area for journalists Are you looking for a…

CV-Eichmuller.pdf PDF, 136.26 KB

Last update: : 03.02.2025

Stefan Eichmüller, PhD Apl. Professor, Head of the Research Group GMP & T Cell Therapy, Qualified Person German Cancer Research Center (DKFZ) Postal Address DKFZ, D210, Im Neuenheimer Feld 280,…

Document

Last update: : 03.02.2025

Digital Oncology at DKFZ integrates cutting-edge data science with cancer research. With a team of approximately 250 researchers across nine divisions, the cross-topic aims to create benchmarks for…

Last update: : 03.02.2025

Sonja Prüssing +49 (0) 6221 423474 B460 Technician Sonja studied biological chemistry at the University of Applied Sciences in Mannheim as one of the last diploma engineers. During her time in the…

Last update: : 03.02.2025

Dr. Angelika Feldmann +49 (0) 6221 421560 B460 Group Leader Angelika has moved to the Heidelberg in October 2021 to start the Research Group ‘Mechanisms of Genome Control’. Here, she can follow her…

Last update: : 03.02.2025

Belinda Blum +49 (0) 6221 423474 B460 PhD student Belinda holds a Master of Science degree in Biochemistry from the University of Würzburg, Germany. She joined the Feldmann lab as a PhD student to…

Last update: : 03.02.2025

Research At least 20% of human malignancies are caused by consequences of persistent infections. Cancers caused by infectious agents (e.g. human papillomavirus – HPV) are attractive targets for…

Form

Form data is loaded ...